SCHEMBL21998497

SCHEMBL21998497

C=CC(=O)Nc1ccc(/C=C/c2ccc3c(c2)OCO3)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.67
KDM4E B2RXH2 6/20 0.65
MAPT P10636 3/20 0.65
ALDH1A1 P00352 4/20 0.61
SMN1; SMN2 Q16637 4/20 0.61
TRPV1 Q8NER1 2/20 0.61
MEN1 O00255 2/20 0.61
NPC1 O15118 2/20 0.61
RAB9A P51151 2/20 0.61
KMT2A Q03164 2/20 0.61
HDAC6 Q9UBN7 1/20 0.56
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
HPGD P15428 1/20 0.54
CYP2C19 P33261 1/20 0.54
PKM P14618 1/20 0.54
CYP19A1 P11511 1/20 0.52
TP53 P04637 1/20 0.52
HDAC4 P56524 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20456546 0.86 SMN1; SMN2 (0.68) MAPTALDH1A1SMN1; SMN2TRPV1MEN1
SCHEMBL23552334 0.84 EPHX2 (0.49) EPHX2KDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL21998489 0.84 SMN1; SMN2 (0.76) EPHX2KDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL21933245 0.83 KDM4E (0.81) EPHX2KDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL21998487 0.83 MAPT (0.76) EPHX2KDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL21998488 0.82 KDM4E (0.78) EPHX2KDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL21996664 0.82 KDM4E (0.74) EPHX2KDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL21998502 0.82 MAPT (0.49) EPHX2KDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL21998490 0.82 TRPV1 (0.80) EPHX2KDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL95349 0.82 KDM4E (0.77) EPHX2KDM4EMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10829466-B2 Stilbene derivative and preparation method thereof BEIJING INSTITUTE OF TECHNOLOGY (CN) 2020-11-10 US disclosed
US-20200148662-A1 NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF BEIJING INSTITUTE OF TECHNOLOGY (CN) 2020-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829466-B2 Stilbene derivative and preparation method thereof STS, F12, GLB1 EPHX2 3414/4885KDM4E 4389/4885MAPT 3955/4885
US-20200148662-A1 NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF STS, F12, STK38L EPHX2 3354/4885KDM4E 4442/4885MAPT 3976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.